A genetic basis for sex differences in Xp11 translocation renal cell carcinoma.
Cell.
2024 Oct 3;187(20):5735-5752.e25. doi: 10.1016/j.cell.2024.07.038. Epub 2024 Aug 20. PubMed PMID:
39168126; PubMed Central PMCID:
PMC11455617.
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition.
Hematol Oncol Clin North Am.
2023 Oct;37(5):1015-1026. doi: 10.1016/j.hoc.2023.05.022. Epub 2023 Jun 28. Review. PubMed PMID:
37385938.
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes.
Hematol Oncol Clin North Am.
2023 Oct;37(5):1027-1040. doi: 10.1016/j.hoc.2023.05.023. Epub 2023 Jun 28. Review. PubMed PMID:
37391289.
Genome-guided discovery of cancer therapeutic targets.
Cell Rep.
2023 Aug 29;42(8):112978. doi: 10.1016/j.celrep.2023.112978. Epub 2023 Aug 10. Review. PubMed PMID:
37572322.
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma.
bioRxiv.
2023 Aug 6;. doi: 10.1101/2023.08.04.552029. PubMed PMID:
37577497; PubMed Central PMCID:
PMC10418269.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist.
2023 May 8;28(5):433-439. doi: 10.1093/oncolo/oyac262. PubMed PMID:
36640141; PubMed Central PMCID:
PMC10166175.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist.
2022 Dec 9;27(12):1041-1047. doi: 10.1093/oncolo/oyac158. PubMed PMID:
35979929; PubMed Central PMCID:
PMC10249266.
Somatic XIST activation and features of X chromosome inactivation in male human cancers.
Cell Syst.
2022 Nov 16;13(11):932-944.e5. doi: 10.1016/j.cels.2022.10.002. Epub 2022 Nov 9. PubMed PMID:
36356577; NIHMSID:NIHMS1932204.
Patterns of structural variation define prostate cancer across disease states.
JCI Insight.
2022 Sep 8;7(17). doi: 10.1172/jci.insight.161370. PubMed PMID:
35943799; PubMed Central PMCID:
PMC9536266.
How splicing confers treatment resistance in prostate cancer.
Elife.
2022 Aug 23;11. doi: 10.7554/eLife.82070. PubMed PMID:
35998026; PubMed Central PMCID:
PMC9398401.
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.
Cell Rep.
2022 Feb 22;38(8):110417. doi: 10.1016/j.celrep.2022.110417. PubMed PMID:
35196489; PubMed Central PMCID:
PMC9036938.
Integrative clinical and molecular characterization of translocation renal cell carcinoma.
Cell Rep.
2022 Jan 4;38(1):110190. doi: 10.1016/j.celrep.2021.110190. PubMed PMID:
34986355; PubMed Central PMCID:
PMC9127595.
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.
Nat Commun.
2021 Jul 12;12(1):4245. doi: 10.1038/s41467-021-24499-6. PubMed PMID:
34253722; PubMed Central PMCID:
PMC8275687.
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Nat Commun.
2021 Feb 5;12(1):808. doi: 10.1038/s41467-021-21068-9. PubMed PMID:
33547292; PubMed Central PMCID:
PMC7865061.
Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Nat Genet.
2020 Aug;52(8):790-799. doi: 10.1038/s41588-020-0664-8. Epub 2020 Jul 20. PubMed PMID:
32690948; PubMed Central PMCID:
PMC10007911.
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
Cell.
2018 Jul 12;174(2):433-447.e19. doi: 10.1016/j.cell.2018.05.036. Epub 2018 Jun 18. PubMed PMID:
29909985; PubMed Central PMCID:
PMC6046279.
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.
Nat Genet.
2018 Jul;50(7):937-943. doi: 10.1038/s41588-018-0155-3. Epub 2018 Jun 28. PubMed PMID:
29955178; PubMed Central PMCID:
PMC6143899.
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
Nature.
2017 Jul 27;547(7664):453-457. doi: 10.1038/nature23007. Epub 2017 Jul 5. PubMed PMID:
28678785; PubMed Central PMCID:
PMC5667900.
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
Lancet Haematol.
2017 Apr;4(4):e157-e164. doi: 10.1016/S2352-3026(17)30026-1. Epub 2017 Mar 2. PubMed PMID:
28259520.
LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.
Genes Dev.
2015 May 15;29(10):1074-86. doi: 10.1101/gad.256693.114. Epub 2015 May 8. PubMed PMID:
25956904; PubMed Central PMCID:
PMC4441054.
Gallbladder lymphoma.
Med Oncol.
2011 Sep;28(3):810-2. doi: 10.1007/s12032-010-9535-y. Epub 2010 Apr 21. PubMed PMID:
20407853.
Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies.
Nat Genet.
2010 Jul;42(7):626-30. doi: 10.1038/ng.593. Epub 2010 May 30. PubMed PMID:
20512147; PubMed Central PMCID:
PMC3069638.
Lin28: A microRNA regulator with a macro role.
Cell.
2010 Feb 19;140(4):445-9. doi: 10.1016/j.cell.2010.02.007. PubMed PMID:
20178735.
Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.
J Biol Chem.
2009 Oct 23;284(43):29269-82. doi: 10.1074/jbc.M109.039115. Epub 2009 Aug 18. PubMed PMID:
19690161; PubMed Central PMCID:
PMC2785557.
A role for Lin28 in primordial germ-cell development and germ-cell malignancy.
Nature.
2009 Aug 13;460(7257):909-13. doi: 10.1038/nature08210. Epub 2009 Jul 5. PubMed PMID:
19578360; PubMed Central PMCID:
PMC2729657.
microRNA expression during trophectoderm specification.
PLoS One.
2009 Jul 3;4(7):e6143. doi: 10.1371/journal.pone.0006143. PubMed PMID:
19582159; PubMed Central PMCID:
PMC2702083.
Lin28 promotes transformation and is associated with advanced human malignancies.
Nat Genet.
2009 Jul;41(7):843-8. doi: 10.1038/ng.392. Epub 2009 May 31. PubMed PMID:
19483683; PubMed Central PMCID:
PMC2757943.
Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28.
J Biol Chem.
2008 Aug 1;283(31):21310-4. doi: 10.1074/jbc.C800108200. Epub 2008 Jun 12. PubMed PMID:
18550544.
Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos.
Nat Genet.
2008 Jul;40(7):921-6. doi: 10.1038/ng.173. Epub 2008 Jun 8. PubMed PMID:
18536715; PubMed Central PMCID:
PMC2690707.
Selective blockade of microRNA processing by Lin28.
Science.
2008 Apr 4;320(5872):97-100. doi: 10.1126/science.1154040. Epub 2008 Feb 21. PubMed PMID:
18292307; PubMed Central PMCID:
PMC3368499.
N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirus-encoded, but not cellular, interleukin 6.
J Exp Med.
2004 Feb 16;199(4):503-14. doi: 10.1084/jem.20031205. PubMed PMID:
14970177; PubMed Central PMCID:
PMC2211829.
What would you like to do?